高级搜索
鞣酸对LLC/cMOAT细胞多药耐药性的逆转机制[J]. 肿瘤防治研究, 2008, 35(09): 630-634. DOI: 10.3971/j.issn.1000-8578.1594
引用本文: 鞣酸对LLC/cMOAT细胞多药耐药性的逆转机制[J]. 肿瘤防治研究, 2008, 35(09): 630-634. DOI: 10.3971/j.issn.1000-8578.1594
Reversal Mechanism of Tannic Acid on Multidrug Resistant of LLC/cMOAT Cells[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 630-634. DOI: 10.3971/j.issn.1000-8578.1594
Citation: Reversal Mechanism of Tannic Acid on Multidrug Resistant of LLC/cMOAT Cells[J]. Cancer Research on Prevention and Treatment, 2008, 35(09): 630-634. DOI: 10.3971/j.issn.1000-8578.1594

鞣酸对LLC/cMOAT细胞多药耐药性的逆转机制

Reversal Mechanism of Tannic Acid on Multidrug Resistant of LLC/cMOAT Cells

  • 摘要: 目的本研究探讨鞣酸(Tannic acid,TA)对LLC/cMOAT细胞多药耐药性的逆转作用及其可能机制。方法采用MTT法检测LLC/CMV和LLC/cMOAT细胞对各种化疗药物的敏感性以及在不同浓度的TA处理下细胞的存活状态;确定TA的非细胞毒性浓度以及在该浓度下各梯度浓度处理时细胞的存活率;采用流式细胞仪技术检测使用非细胞毒性浓度的TA处理前后LLC/cMOAT细胞内柔红霉素(DNR)浓度变化、细胞周期阻滞及对凋亡的影响。结果LLC/cMOAT细胞对羟基喜树碱(CPT-11),阿霉素(ADM),顺铂(DDP)和长春新碱(VCR)均有不同程度的耐药,其耐药倍数分别是2.08、3.02、4.01和9.31,对依托泊苷(VP-16)、紫衫醇(TAX)无明显耐药,10.0μmol/L浓度以下的TA对LLC/CMV和LLC/cMOAT细胞无明显细胞毒性,2.5、5.0、10.0μmol/L浓度的TA能显著降低LLC/cMOAT细胞的IC50(P<0.05),其逆转倍数分别为5.09、6.33、7.76倍;细胞内DNR荧光强度随着TA浓度的增高而明显增强;TA作用细胞12h可使G1期细胞数百分比由(46.35±3.74) %增至(66. 43 ±5. 87) %, 阻滞细胞于G1期; TA 与VCR 联合处理细胞24 h 和48 h 时凋亡率分别为12. 1 %和19. 0 %, 与处理前(1. 65 %) 相比提高明显;使用2. 5μmol/ L 、5.0μmol/ L 和10. 0μmol/ L 浓度的TA 与VCR 共同处理细胞24 h 后,凋亡率由处理前的4. 96 %分别提高到11. 2 %、17. 9 %和25. 1 %。结论 TA能部分逆转LLC/ cMOAT 细胞的多药耐药,显著提高耐药细胞内DNR 荧光强度并呈浓度依赖性,阻滞细胞周期于G1 期,并可诱导细胞凋亡,呈时间、剂量依赖性,其机制可能与抑制化疗药物外排、增加细胞内药物浓度以及诱导细胞凋亡有关。

     

    Abstract: Objective To investigate the reversal effects of tannic acid(TA) on the multidrug resistance of LLC/cMOAT cells and the possible mechanism. Methods MTT assay was used to determine the sensitivity of LLC/CMV and LLC/cMOAT cells to the various kinds of chemotherapeutics,and the activity of LLC/CMV and LLC/cMOAT cells treated with different concentrations of TA. The non-cytotoxic concentrations of TA were determined for the cells and the reversal effects of the chemotherapeutics were observed. The intracellular concent ration of DNR, the cell cycle dist ribution and the apoptosis rate of the cells t reated with different concent rations of TA were determined by flow cytomet ry ( FCM) . Results  LLC/ cMOAT cells were resistant to CPT-11, ADM, DDP, VCR to a certain extent, and not resistant to VP-16 、TAX. At 10. 0μmol/ L and below, TA was not significantly cytotoxic to LLC/ CMV and LLC/cMOAT cells. TA at the concent ration of 2. 5, 5. 0, 10. 0μmol/ L may remarkably decrease IC50 of LLC/cMOAT cells ( P < 0. 05) . The int racellular DNR fluorescence intensity in LLC/ cMOAT cells was significantly enhanced with the increase of TA concent ration. The cells at G1 stage increased f rom (46. 35 ± 3. 74) % to (66. 43 ±5. 87) % when t reated with TA at 5. 0μmol/ L for 12 hours. The cell apoptosis was enhanced in a time-and concent ration-dependent manner by t reating with TA. Conclusion  TA is able to reverse the multidrug resistance of LLC/ cMOAT cells and may remarkably raise drug concent rations in concent ration-dependent manner, TA is able to block cell cycle at G1 stage, and it s function of inducing apoptosis act s in time-and dose-depended manner. The mechanism may involve the decrease of chemother apeutics excretion, the increase of int racellular drug concent ration, growth arrest at G1 and apoptosis.

     

/

返回文章
返回